By Randy Dotinga
HealthDay Reporter
TUESDAY, May 15 (HealthDay News) — Should Americans be able to buy a test at the drugstore and use it to determine whether they’re infected with the virus that causes AIDS?
A U.S. Food and Drug Administration advisory panel plans to debate this question Tuesday, and the answer the panel arrives at could pave the way toward a new era in HIV testing.
TUESDAY, May 15 (HealthDay News) — The lives of more than 740,000 people in nine African countries were saved between 2004 and 2008 by the U.S. President’s Emergency Plan for AIDS Relief, a new study indicates.
The program reduced adults’ risk of death from all causes by 16 percent to 20 percent during those four years, Stanford University School of Medicine researchers found. The researchers said this is the first study to show a decline in all-cause deaths related to the program.
MONDAY, May 14 (HealthDay News) — People with HIV/AIDS are four times more likely to die of sudden cardiac arrest than those in the general population, a new study finds.
The findings held true even for people with well-controlled HIV, according to researchers from the University of California, San Francisco (UCSF). In sudden cardiac arrest, also referred to as sudden cardiac death, the heart suddenly and unexpectedly stops beating.
By Randy Dotinga
HealthDay Reporter
WEDNESDAY, May 2 (HealthDay News) — New research shows that gene therapy can have long-lasting effects on the immune cells of HIV patients — a promising sign — even though the specific treatment being studied did not eradicate the virus.
This approach is one of several gene therapy strategies that are being investigated by scientists as possible ways to keep the AIDS virus from spreading in the blood.
TUESDAY, April 17 (HealthDay News) — A once-a-day pill to prevent HIV infection could significantly reduce the spread of the AIDS-causing virus, but would only be cost-effective if limited to men at very high risk for HIV infection, according to a new study.
Stanford University researchers created an economic model to analyze the use of the combination drug tenofovir-emtricitabine (brand name Truvada). A clinical trial found that the drug reduced a person’s risk of HIV infection by an average of 44 percent when taken daily. In some people, the drug reduced the risk by 73 percent.
MONDAY, April 16 (HealthDay News) — Women with HIV are at increased risk for anal cancer, a new study finds.
Researchers at Montefiore Medical Center in New York City looked at 715 HIV-infected women and found that 10.5 percent had some form of anal disease and about one-third of those women had precancerous disease.
WEDNESDAY, March 28 (HealthDay News) — Early, 24-week treatment for people newly infected with HIV can delay the need at a later date to start long-term treatment, according to a new study.
The study included 168 newly infected HIV patients who were randomly selected to receive no treatment, 24 weeks of treatment with combined antiretroviral drugs or 60 weeks of the drugs.
FRIDAY, March 2 (HealthDay News) — Women become less likely to insist on condom use during the course of their first year of college, new research finds.
Declining condom use was most notable among women who drank excessively, who had worse grades and who came from poorer backgrounds.
By Steven Reinberg
HealthDay Reporter
MONDAY, Feb. 20 (HealthDay News) — Deaths from hepatitis C have increased steadily in the United States in recent years, in part because many people don’t know they have disease, a new government report says.
More Americans now die of hepatitis C than from HIV, the AIDS-causing virus, according to 1999-2007 data reviewed by the U.S. Centers for Disease Control and Prevention (CDC). And most of those dying are middle-aged.
THURSDAY, Feb. 16 (HealthDay News) — In studying how HIV is transmitted, researchers have discovered that some African sex workers are naturally resistant to the virus, a finding that could influence prevention efforts.
These women are protected by an unusually weak inflammatory response in their vaginas, the scientists noted.
| Text Size: |  |
|
